Asset Dedication, LLC Merck & Co., Inc. Transaction History

Asset Dedication, LLC

$1.25 Billion
Q4 2024

A detailed history of Asset Dedication, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Asset Dedication, LLC holds 31,359 shares of MRK stock, worth $2.81 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

31,359

Previous 46,777 32.96%

Holding current value

$2.81 Million

Previous $5.31 Million 41.27%

% of portfolio

0.25%

Previous 0.36%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 22, 2025	SELL	$96.31 - $114.76 $1.48 Million - $1.77 Million	-15,418 Reduced 32.96%	31,359 $3.12 Million
Q3 2024 Oct 15, 2024	SELL	$111.15 - $128.97 $912,763 - $1.06 Million	-8,212 Reduced 14.93%	46,777 $5.31 Million
Q2 2024 Aug 06, 2024	BUY	$123.8 - $132.96 $36,273 - $38,957	293 Added 0.54%	54,989 $6.81 Million
Q1 2024 Apr 16, 2024	BUY	$113.24 - $131.95 $85,835 - $100,018	758 Added 1.41%	54,696 $7.25 Million
Q4 2023 Feb 08, 2024	BUY	$100.18 - $109.02 $45,982 - $50,040	459 Added 0.86%	53,938 $5.89 Million
Q3 2023 Nov 13, 2023	BUY	$102.95 - $114.33 $84,521 - $93,864	821 Added 1.56%	53,479 $5.53 Million
Q2 2023 Aug 21, 2023	BUY	$108.61 - $118.38 $62,233 - $67,831	573 Added 1.1%	52,658 $6.09 Million
Q1 2023 Apr 21, 2023	SELL	$102.94 - $114.86 $117,557 - $131,170	-1,142 Reduced 2.15%	52,085 $5.54 Million
Q4 2022 Jan 19, 2023	BUY	$87.44 - $112.11 $345,650 - $443,170	3,953 Added 8.02%	53,227 $5.91 Million
Q3 2022 Oct 27, 2022	BUY	$84.53 - $94.96 $884,352 - $993,471	10,462 Added 26.96%	49,274 $4.25 Million
Q2 2022 Jul 19, 2022	BUY	$83.49 - $94.64 $268,420 - $304,267	3,215 Added 9.03%	38,812 $3.53 Million
Q1 2022 Apr 21, 2022	BUY	$73.51 - $82.4 $395,704 - $443,559	5,383 Added 17.82%	35,597 $2.92 Million
Q4 2021 Jan 21, 2022	BUY	$72.28 - $90.54 $203,468 - $254,870	2,815 Added 10.27%	30,214 $2.32 Million
Q3 2021 Oct 18, 2021	BUY	$71.68 - $78.83 $4,014 - $4,414	56 Added 0.2%	27,399 $2.07 Million
Q2 2021 Jul 21, 2021	BUY	$70.31 - $77.77 $575,065 - $636,080	8,179 Added 42.68%	27,343 $2.12 Million
Q1 2021 May 03, 2021	SELL	$68.86 - $81.11 $642,876 - $757,242	-9,336 Reduced 32.76%	19,164 $1.49 Million
Q4 2020 Jan 28, 2021	SELL	$71.77 - $79.65 $63,014 - $69,932	-878 Reduced 2.99%	28,500 $2.33 Million
Q3 2020 Oct 20, 2020	BUY	$73.18 - $82.95 $763,267 - $865,168	10,430 Added 55.05%	29,378 $2.42 Million
Q2 2020 Aug 24, 2020	BUY	$70.42 - $80.13 $113,164 - $128,768	1,607 Added 9.27%	18,948 $1.46 Million
Q1 2020 May 05, 2020	SELL	$63.36 - $87.82 $438,577 - $607,890	-6,922 Reduced 28.53%	17,341 $1.33 Million
Q4 2019 Jan 31, 2020	BUY	$77.58 - $87.54 $244,687 - $276,101	3,154 Added 14.94%	24,263 $2.2 Million
Q3 2019 Oct 17, 2019	BUY	$76.08 - $82.93 $62,766 - $68,417	825 Added 4.07%	21,109 $1.77 Million
Q2 2019 Jul 23, 2019	BUY	$69.84 - $81.59 $65,998 - $77,102	945 Added 4.89%	20,284 $1.69 Million
Q1 2019 Apr 19, 2019	BUY	$69.58 - $79.36 $121,208 - $138,245	1,742 Added 9.9%	19,339 $1.6 Million
Q4 2018 Feb 12, 2019	BUY	$65.24 - $75.71 $183,520 - $212,972	2,813 Added 19.03%	17,597 $1.35 Million
Q3 2018 Oct 26, 2018	BUY	$57.69 - $67.84 $94,438 - $111,054	1,637 Added 12.45%	14,784 $1.05 Million
Q2 2018 Aug 13, 2018	BUY	$50.83 - $59.72 $52,964 - $62,228	1,042 Added 8.61%	13,147 $789,000
Q1 2018 Apr 19, 2018	SELL	$50.96 - $59.23 $179,684 - $208,844	-3,526 Reduced 22.56%	12,105 $662,000
Q4 2017 Jan 17, 2018	SELL	$51.62 - $61.64 $195,330 - $233,245	-3,784 Reduced 19.49%	15,631 $880,000
Q3 2017 Oct 18, 2017	BUY	$58.67 - $63.13 $1.14 Million - $1.23 Million	19,415	19,415 $1.23 Million

Others Institutions Holding MRK

# of Institutions

3,954

Shares Held

1.86B

Call Options Held

16M

Put Options Held

15M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $227B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Dedication, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Asset Dedication, LLC with notifications on news.

Account

Asset Dedication, LLC Merck & Co., Inc. Transaction History